PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advancing Research of SPU-21 in Human Synovial Tissue
Nov 21, 2022
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its novel joint homing peptides targeting rheumatoid arthritis (“RA”), designated as SPU-21, in human synovial tissue surrounding joints and tendons. The three-month study will assess the binding affinity of the peptide in healthy human and RA synovial tissue, with initial data expected during the first quarter of 2023. “SPU-21 was shown to inhibit arthritic progression in a preclinical animal model, so we are proceeding to advance our research into human synovial tissue, where we will first assess binding affinity,” said Eric Weisblum, CEO of Silo Pharma. “Positive data from this important study could support further research into the interaction of our joint homing peptide as a potential therapy for autoimmune disorders such as rheumatoid arthritis and inflammation. We look forward to progressing our development of SPU-21 through our valued collaboration with the University of Maryland, Baltimore.”
To view the full press release, visit https://ibn.fm/fKPlY
About Silo Pharma Inc.
Silo Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which it believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
More News
Jesse Baird’s ‘resignation’ texted day after he was allegedly murdered
TV presenter Jesse Baird's resignation was texted to his new boss the day after he was allegedly murdered.
Point of Law wins 2026 Melbourne Cup
Point Of Law, the horse previously owned by King Charles, stormed home on the final straight to win the Melbourne Cup.
Kate McClymont gives evidence in Alan Jones trial
Award-winning journalist Kate McClymont alleged indecent assaults by Alan Jones and said she didn’t offer benefits to complainants for stories.
Transport authorities demand answers after 4-hour parking meter outage
Hong Kong’s transport authorities have launched an investigation into a four-hour outage of the city’s parking meter system on Tuesday morning and ordered operator HKT to submit a report. The Transport Department said HKT had notified it at about 8.20am that the system was out of service and urgent repairs were under way. Shortly after noon, the department said the system had resumed normal operation following repairs. “The Transport Department will continue to urge the operator to thoroughly...
RBA and economists say government spending is boosting inflation
Both the Reserve Bank and economists say government spending is driving inflation.
The Catholic threat to patients’ right
The NSW government is seemingly complicit in a quiet takeover of publicly funded hospitals by a Catholic Church group.
‘Exit plans’ and ‘god work’: Notes from accused wife-killer’s home shown to jury
A blood-stained towel and mat were also found inside the bathroom, the jury in Robert Crawford’s trial heard.
One Nation volunteer bashed with baseball bat outside Victorian home
A volunteer is recovering from a brain bleed after confronting alleged vandals targeting campaign signs at his property.
RBA lifts interest rates for fifth time this year
The Reserve Bank has hiked interest rates by 25 basis points, the fifth rate rise this year.
Profit, clicks didn’t drive reporting: Kate McClymont testifies in Jones trial
The Herald’s chief investigative reporter told Alan Jones’ criminal trial that she gave a statement to police about the ex-2GB broadcaster in 2024.
‘Everyone is feeling the pain’: Interest rate hike hits Sydney hard
As Sydneysiders come to terms with the fifth rate rise this year, many are worried about how they will find the extra cash.
Hoyoverse’s Petit Planet launches on 4 December, with a Switch 2 version coming in 2027
The free-to-play life simulation game arrives first on PC and mobile, where players can build a planet, meet its residents and explore the Starsea.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.